Rebecca Chambers is the Chief Financial Officer at Veracyte Inc., a leading genomic diagnostics company focused on improving patient care through innovative diagnostic solutions. With an extensive background in finance and strategic planning, Rebecca has been instrumental in steering Veracyte towards financial stability and growth. Prior to joining Veracyte, she held several high-profile positions in the biotechnology and healthcare sectors, including a tenure as the CFO at a prominent medical device company, where she successfully led the organization through a period of significant expansion and profitability. At Veracyte, Rebecca oversees all financial operations, including financial planning and analysis, accounting, and investor relations. Her strategic foresight and deep understanding of the industry have been crucial in navigating the company through the complexities of the diagnostics market. Under her leadership, Veracyte has seen a marked increase in revenue and market share, thanks to her adept management of the company's financial resources and her ability to forge strong relationships with investors and stakeholders. Rebecca's achievements at Veracyte also include the successful execution of several key acquisitions that have broadened the company's portfolio and enhanced its competitive edge in the genomic diagnostics space. Rebecca holds an MBA from a top-tier business school and is a Certified Public Accountant (CPA). Her commitment to excellence and her passion for advancing healthcare through innovative diagnostics make her a vital asset to Veracyte. In addition to her professional accomplishments, Rebecca is actively involved in mentoring young professionals in the finance and healthcare industries, further solidifying her reputation as a leader dedicated to fostering the next generation of talent.